Gene · 9682
Papers1,858
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 1,858
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interaction of NEP with G Protein Pathway Suppressor 2 Facilitates Influenza A Virus Replication by Weakening the Inhibition of GPS2 to RNA Synthesis and Ribonucleoprotein Assembly. | J Virol | 2021 | 33658351 | PubTator, text mining | PubMed |
| GASC1 promotes glioma progression by enhancing NOTCH1 signaling. | Mol Med Rep | 2021 | 33649841 | PubTator, text mining | PubMed |
A potential association of RNF219-AS1 with ADHD: Evidence from categorical analysis of clinical phenotypes and from quantitative exploration of executive function and white matter microstructure endophenotypes. | CNS Neurosci Ther | 2021 | 33644999 | PubTator, text mining | PubMed |
| Dissecting the impact of regional identity and the oncogenic role of human-specific NOTCH2NL in an hESC model of H3.3G34R-mutant glioma. | Cell Stem Cell | 2021 | 33631117 | PubTator, text mining | PubMed |
| Histone demethylase KDM4A overexpression improved the efficiency of corrected human tripronuclear zygote development. | Mol Hum Reprod | 2021 | 33599278 | PubTator, text mining | PubMed |
| The emerging role of KDM5A in human cancer. | J Hematol Oncol | 2021 | 33596982 | PubTator, text mining | PubMed |
| MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation. | BMC Cancer | 2021 | 33588776 | PubTator, text mining | PubMed |
| Structural mechanism of bivalent histone H3K4me3K9me3 recognition by the Spindlin1/C11orf84 complex in rRNA transcription activation. | Nat Commun | 2021 | 33574238 | PubTator, text mining | PubMed |
| A pediatric brain tumor atlas of genes deregulated by somatic genomic rearrangement. | Nat Commun | 2021 | 33568653 | PubTator, text mining | PubMed |
| Epigenetic signatures in cancer: proper controls, current challenges and the potential for clinical translation. | Genome Med | 2021 | 33568205 | PubTator, text mining | PubMed |
| The COMPASS-like complex modulates fungal development and pathogenesis by regulating H3K4me3-mediated targeted gene expression in Magnaporthe oryzae. | Mol Plant Pathol | 2021 | 33559339 | PubTator, text mining | PubMed |
| USP9X-mediated KDM4C deubiquitination promotes lung cancer radioresistance by epigenetically inducing TGF-β2 transcription. | Cell Death Differ | 2021 | 33558705 | PubTator, text mining | PubMed |
| Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition. | Clin Cancer Res | 2021 | 33542077 | PubTator, text mining | PubMed |
| TET-dioxygenase deficiency in oncogenesis and its targeting for tumor-selective therapeutics. | Semin Hematol | 2021 | 33509440 | PubTator, text mining | PubMed |
| Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder. | Nat Commun | 2021 | 33495439 | PubTator, text mining | PubMed |
| Mechanistic insights into KDM4A driven genomic instability. | Biochem Soc Trans | 2021 | 33492339 | PubTator, text mining | PubMed |
| 17-DMAG dually inhibits Hsp90 and histone lysine demethylases in alveolar rhabdomyosarcoma. | iScience | 2021 | 33490904 | PubTator, text mining | PubMed |
| IOX1 protects from TGF-β induced fibrosis in LX-2 cells via the regulation of extracellular matrix protein expression. | Exp Ther Med | 2021 | 33488789 | PubTator, text mining | PubMed |
| Long-read transcriptome sequencing reveals abundant promoter diversity in distinct molecular subtypes of gastric cancer. | Genome Biol | 2021 | 33482911 | PubTator, text mining | PubMed |
| p53 affects epigenetic signature on SOCS1 promoter in response to TLR4 inhibition. | Cytokine | 2021 | 33476981 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9682/papers?page=34